Review Article

Gram-Negative Infections in Adult Intensive Care Units of Latin America and the Caribbean

Table 1

Infection rates in ICUs of Argentinian and Brazilian hospitals.

ReferenceStudy designLocationYear of studyNumber of patientsRate of infection

Lossa et al. 2008 [16]Cross-sectional, multicenterArgentina nationwide2004 and 2005356(i) Pooled prevalence, 24% (95% CI, 20%–29%) 
(a) Pneumonia, 43% 
(b) BSI, 21% 
(c) UTI, 13%

Luna et al. 2003 [17]Prospective, multicenterBuenos Aires, Argentina1999–2001472(i) VAP incidence, 63/472 (13%)

Toufen Junior et al. 2003 [18]1-day point prevalenceSão Paulo, Brazil2000126(i) Overall prevalence, 72/126 (57%) 
(a) CAI, 15/72 (21%) 
(b) Non-ICU nosocomial infection, 24/72 (33%) 
(c) ICU-acquired infection, 22/72 (31%) 
(d) Undefined, 11/72 (15%)

de Queiroz Guimarães and Rocco 2006 [19]Prospective observationalRio de Janeiro, Brazil1999–2001278(i) VAP prevalence, 38% (36 cases/1000 ventilator days)

Lima et al. 2007 [20]Prospective observationalSão Paulo, Brazil200671(i) Prevalence, 47/71 (66%)

da Rocha et al. 2008 [21]Prospective observationalUberlândia, Brazil2005-2006275(i) VAP prevalence, 31% (25 cases/1000 ventilator days)

Rodrigues et al. 2009 [22]Prospective observationalRio de Janeiro, Brazil2005–2007233(i) VAP prevalence, 27% (17 cases/1000 ventilator days)

de Oliveira et al. 2010 [23]Prospective observationalMinas Gerais, Brazil2005–20082300(i) CAI, 437/2300 (19%) 
(a) 284 (12%) patients colonized by resistant microorganisms during ICU hospitalization, 61% of whom developed an infection 
(ii) Nosocomial infection, 311/2300 (14%) 
(a) 84/311 (27%) owing to resistant pathogens

ICU: intensive care unit, CI: confidence interval, BSI: bloodstream infection, UTI: urinary tract infection, VAP: ventilator-acquired pneumonia, and CAI: community-acquired infection.